Skip to main content
NewslettersWatchlist

Pfizer Inc(PFE-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low25.23
Day High25.46
Open:25.35
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today
Motley Fool
3 No-Brainer Stocks to Buy With $100 Right Now
Newswire.ca
World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"
Barchart
5 Underperforming Stocks That Look Ready to Rebound, According to Goldman
Motley Fool
Better Growth Play: Merck or The Vanguard Growth Index Fund?
Motley Fool
Is Pfizer Stock a Buy?
Motley Fool
Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.
Motley Fool
The Smartest Dividend Stocks to Buy With $400 Right Now
Motley Fool
Down 60% From Its 52-Week High, Is Novavax Stock a Buy?
Motley Fool
2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever
Motley Fool
Is Pfizer Stock the Biggest Bargain in the S&P 500?
Barchart
2 Defensive Stocks to Buy Now as 'Higher For Longer' Woes Rattle Markets
Motley Fool
Where Will Pfizer Stock Be in 10 Years?
Motley Fool
How's AT&T Handling Things?
Motley Fool
2 Ultra-High-Yield Dividend Stocks to Buy and Hold Forever
Motley Fool
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.
Motley Fool
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
Motley Fool
This S&P 500 Dividend Stock Could Be the Best Bad-News Buy on the Market
Motley Fool
Forget Nvidia: 3 Prominent Billionaire Investors Are Selling It and Buying These 6 Value Stocks Instead
Motley Fool
3 No-Brainer Dividend Stocks to Buy in April
Motley Fool
Got $1,000? 2 Phenomenal Growth Stocks to Buy in 2024 and Hold at Least a Decade
Barchart
Down 32% in a Year, Should Investors Buy the Dip in Pfizer Stock?
Motley Fool
3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
Motley Fool
4 Stocks High on My Watchlist to Buy
Motley Fool
3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screamings Buys in April
Motley Fool
2 Stocks Down 30% and 27% to Buy and Hold
Motley Fool
Better Recovery Story Buy: Pfizer vs Moderna
Motley Fool
Prediction: Pfizer Won't Acquire Viking Therapeutics. Here's Why.
Motley Fool
3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
Motley Fool
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever
Motley Fool
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition

Profile

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.'The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.